Holcomb John Bradley
SEC insider (Form 3/4/5 filer). CIK 0002092279. Director at MiNK Therapeutics, Inc. (INKT). 5 reported Form 4/5 transactions since Sep 2024; latest on Sep 1, 2026. Located in NEW YORK, NY.
Companies Holcomb John Bradley has filed insider reports for
- MiNK Therapeutics, Inc. (INKT): Director
Holcomb John Bradley
CIK: 0002092279
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)5 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
INKT
MiNK Therapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Sep 1, 2026INKT
MiNK Therapeutics, Inc.
AwardDirect1.2K shares at avg. $10.95$14K - Jun 1, 2026INKT
MiNK Therapeutics, Inc.
AwardDirect1.1K shares at avg. $12.38$14K - Mar 2, 2026INKT
MiNK Therapeutics, Inc.
AwardDirect1.2K shares at avg. $10.90$14K - Dec 1, 2025INKT
MiNK Therapeutics, Inc.
AwardDirect1.1K shares at avg. $11.09$13K - Sep 23, 2025INKT
MiNK Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
4.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 1, 2026 | INKT MiNK Therapeutics, Inc. | Award | 1,233 | $10.95 | $13,501 | Direct |
| Jun 1, 2026 | INKT MiNK Therapeutics, Inc. | Award | 1,091 | $12.38 | $13,507 | Direct |
| Mar 2, 2026 | INKT MiNK Therapeutics, Inc. | Award | 1,239 | $10.90 | $13,505 | Direct |
| Dec 1, 2025 | INKT MiNK Therapeutics, Inc. | Award | 1,128 | $11.09 | $12,510 | Direct |
| Sep 23, 2025 | INKT MiNK Therapeutics, Inc. | Award Stock Option (Right to Buy) | 4,174 | - | - | Direct |
1-5 of 5 transactions